Key result
The novel MYH6 R1822_E1823dup variant co-segregated with familial atrial septal defect secundum and impaired myofibril formation while increasing apoptosis in vitro.
Why the study?
Atrial septal defect, secundum (ASD II) is the second most common congenital heart defect in China, but the genetic etiology of familial ASD II remains elusive.
Does the MYH6 R1822_E1823dup variant cause familial atrial septal defect?
Observational
Does the MYH6 R1822_E1823dup variant cause familial atrial septal defect?
The identification of a novel MYH6 insertion mutation expands the genetic spectrum of familial ASD II and provides a molecular basis for genetic counseling.
Answers are grounded in this paper and cite their sources.
Supports MYH6 screening in familial ASD II; leaves open clinical adoption pending replication.
Atrial septal defect, secundum (ASD Ⅱ, OMIM: 603642) is the second common congenital heart defect (CHD) in China. However, the genetic etiology of familial ASD II remains elusive. Using whole-exome sequencing (WES) and Sanger sequencing, we identified a novel myosin heavy chain 6 (MYH6) gene insertion variation, NM_002471.3:c.5465_5470dup (R1822_E1823dup), in a large Chinese Han family with ASD II. The variant R1822_E1823dup co-segregated with the disease in this family with autosomal dominant inheritance. The insertion variant located in the coiled-coil domain of the MYH6 protein, which is highly conserved across homologous myosin proteins and species. In transfected myoblast C2C12 cell lines, the MYH6 R1822_E1823dup variant significantly impaired myofibril formation and increased apoptosis but did not significantly reduce cell viability. Furthermore, molecular simulations revealed that the R1822_E1823dup variant impaired the myosin α-helix, increasing the stability of the coiled-coil myosin dimer, suggesting that this variant has an effect on the coiled-coil domain self-aggregation. These findings indicate that R1822_E1823dup variant plays a crucial role in the pathogenesis of ASD II. Collectively, our findings expand the spectrum of MYH6 variations associated with familial ASD II and may provide a molecular basis in genetic counseling and prenatal diagnosis for this Chinses family.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2020) conducted an observational in Atrial septal defect, secundum (ASD II). MYH6 R1822_E1823dup variant was evaluated on Genetic co-segregation and in vitro myofibril formation and apoptosis. The novel MYH6 R1822_E1823dup variant co-segregated with familial atrial septal defect secundum and impaired myofibril formation while increasing apoptosis in vitro.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: